Email updates

Keep up to date with the latest news and content from BMC Microbiology and BioMed Central.

Open Access Research article

amiA is a negative regulator of acetamidase expression in Mycobacterium smegmatis

Tanya Parish1*, Jane Turner2 and Neil G Stoker

Author Affiliations

1 Department of Medical Microbiology, Barts and the London, Queen Mary's School of Medicine and Dentistry, London, UK

2 Department of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK

For all author emails, please log on.

BMC Microbiology 2001, 1:19  doi:10.1186/1471-2180-1-19

Published: 31 August 2001

Abstract

Background

The acetamidase of Mycobacterium smegmatis is a highly inducible enzyme. Expression of this enzyme is increased 100-fold when the substrate acetamide is present. The acetamidase gene is found immediately downstream of three open reading frames. Two of these are proposed to be involved in regulation.

Results

We constructed a deletion mutant in one of the upstream ORFs (amiA). This mutant (Mad1) showed a constitutively high level of acetamidase expression. We identified four promoters in the upstream region using a β-galactosidase reporter gene. One of these (P2) was inducible in the wild-type, but was constitutively active in Mad1.

Conclusions

These results demonstrate that amiA encodes a negative regulatory protein which interacts with P2. Since amiA has homology to DNA-binding proteins, it is likely that it exerts the regulatory effect by binding to the promoter to prevent transcription.